Related Experiment Video
Updated: Aug 7, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray
Rong Hu1, Changjiang Xu, Guoxiang Shen
1Graduate Program in Pharmaceutical Science, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.
Abstract:
Electrophiles generated during metabolic activation of carcinogens and reactive oxygen species formed from endogenous and exogenous sources might play a significant role in carcinogenesis. Cancer chemoprevention by induction of phase II detoxifying enzymes to counteract the insults of these reactive intermediates is under intensive investigation. Nrf2, a bZIP transcription factor, plays a central role in the regulation of phase II genes by binding to the antioxidant response element (ARE) in their promoters. Identification of novel Nrf2-regulated genes is likely to provide insight into cellular defense systems against the toxicities of electrophiles and oxidants and may define effective targets for achieving cancer chemoprevention. Phenethyl isothiocyanate (PEITC) is a promising chemopreventive agent that exerts its effects by induction of phase II enzymes via activation of Nrf2. In the present study, a transcriptional profile of liver of the wild-type (Nrf2+/+) and knock-out (Nrf2-/-) mice after treatments with vehicle or PEITC at 3 h and at 12 h was generated using the Affymetrix Mouse Genome 430 2.0 Array. Comparative analysis of gene expression changes between different treatment groups of wild-type and Nrf2-deficient mice facilitated identification of numerous genes regulated by Nrf2. These Nrf2-dependent and PEITC-inducible genes include known detoxication enzymes, as well as novel xenobiotic-metabolizing genes regulated by Nrf2 such as CYP 2c55, CYP 2u1 and aldehyde oxidase. Unexpected clusters included genes for heat shock proteins, ubiquitin/26 S proteasome subunits, and lipid metabolism molecules. Collectively, the identification of these genes not only provides novel insight into the effect of PEITC on global gene expression and chemoprevention, but also reveals the role of Nrf2 in those processes, which would confer cancer chemopreventive future.
Insights
Phenethyl isothiocyanate (PEITC) activates the Nrf2 pathway, inducing detoxifying enzymes and other genes. This study identifies novel Nrf2-regulated genes, offering insights into cancer chemoprevention strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Carcinogenesis involves electrophiles and reactive oxygen species.
- Cancer chemoprevention strategies focus on inducing phase II detoxifying enzymes.
- Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor regulating these enzymes.
Purpose of the Study:
- To identify novel Nrf2-regulated genes involved in cellular defense.
- To understand the role of Nrf2 in cancer chemoprevention.
- To investigate the effect of Phenethyl isothiocyanate (PEITC) on global gene expression.
Main Methods:
- Transcriptional profiling of wild-type and Nrf2-knockout mouse liver using Affymetrix Mouse Genome 430 2.0 Array.
- Comparative gene expression analysis after vehicle or PEITC treatment.
- Identification of Nrf2-dependent and PEITC-inducible genes.
Main Results:
- Numerous Nrf2-dependent genes were identified, including known detoxifying enzymes and novel xenobiotic-metabolizing genes (e.g., CYP 2c55, CYP 2u1, aldehyde oxidase).
- Unexpected gene clusters related to heat shock proteins, ubiquitin/26 S proteasome subunits, and lipid metabolism were observed.
- PEITC treatment significantly altered gene expression profiles in a Nrf2-dependent manner.
Conclusions:
- The study provides novel insights into PEITC's effects on global gene expression and chemoprevention.
- Nrf2 plays a crucial role in mediating PEITC's effects and conferring cancer chemopreventive properties.
- Identification of these genes offers potential targets for future cancer chemoprevention therapies.
